Legacy Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
44,753
-295
-0.7% -$68.8K 2.01% 12
2026
Q1
$11M Buy
45,048
+1,171
+3% +$273K 2.11% 10
2025
Q4
$9.08M Buy
43,877
+2,679
+7% +$530K 1.7% 20
2025
Q3
$7.64M Buy
41,198
+1,642
+4% +$281K 1.51% 21
2025
Q2
$6.04M Sell
39,556
-2,539
-6% -$390K 1.48% 24
2025
Q1
$6.98M Buy
42,095
+1,173
+3% +$184K 1.68% 21
2024
Q4
$5.92M Sell
40,922
-1,839
-4% -$285K 1.37% 29
2024
Q3
$6.93M Buy
42,761
+3,870
+10% +$617K 1.59% 22
2024
Q2
$5.68M Sell
38,891
-386
-1% -$57.4K 1.41% 26
2024
Q1
$6.21M Buy
39,277
+120
+0.3% +$19.1K 1.55% 24
2023
Q4
$6.14M Buy
39,157
+3
+0% +$460 1.6% 19
2023
Q3
$6.1M Buy
39,154
+492
+1% +$81.2K 1.77% 13
2023
Q2
$6.4M Buy
38,662
+512
+1% +$82.6K 1.76% 13
2023
Q1
$5.91M Buy
38,150
+43
+0.1% +$6.94K 1.76% 11
2022
Q4
$6.73M Buy
+38,107
New +$6.58M 2.08% 10

Other funds holding JNJ

Legacy Trust's JNJ Position: Q2 2026 in Review

Legacy Trust reduced its Johnson & Johnson (JNJ) stake by 0.65% in Q2 2026, selling an estimated $68.8K and leaving 44,753 shares worth $11.4M. The position accounts for 2.01% of the portfolio, ranked #12.

Legacy Trust first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Legacy Trust held 44,753 shares of Johnson & Johnson worth $11.4M as of Q2 2026.
  • Legacy Trust sold 295 Johnson & Johnson shares in Q2 2026, an estimated $68.8K.
  • Johnson & Johnson made up 2.01% of Legacy Trust's portfolio in Q2 2026, its #12 holding.
  • Legacy Trust first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.